Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global ...

Generic drugmaker Zydus Lifesciences has received tentative approval from the U.S. Food and Drug Administration (FDA) for Rifaximin Tablets, 550 mg. The product is indicated for treatment of ...

Zydus Lifesciences shares were last seen 0.41 per cent up at Rs 891.55. At this price, the stock has slipped 8.43 per cent in 2025 so far. Business Today Desk Updated Apr 30, 2025 12:59 PM IST ...

Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets.

Zydus Lifesciences Ltd in its press release dated April 11, 2025, stated that it has received US Food and Drug Administration (USFDA) final approval for its Emflaza Tablets generic drug marketed ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture Apalutamide Tablets, 60 mg. However, the stock came off highs to trade ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30 at 1:00 PM when the company received final approval from the United States Food and Drug Administration ...

Zydus Lifesciences Ltd receives final approval from US health regulator to manufacture generic version of Methenamine Hippurate tablets The tablets are indicated for prophylactic or suppressive ...

Methenamine Hippurate tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad. Methenamine Hippurate tablets had annual sales of USD 32.6 mn in the United States (IQVIA MAT January 2025).

Zydus Life shares rose 1.85 per cent to settle at Rs 887.95. Despite the mentioned rise, the stock has slipped 8.80 per cent on a year-to-date (YTD) basis.

Zydus receives US FDA final approval for generic Duexis tablets, 800 mg/26.6 mg ...

Fludrocortisone acetate tablets will be produced at the group’s manufacturing site at Moraiya, Ahmedabad. Fludrocortisone acetate tablets had a market value of $19.9 million, per IQVIA July 2024 ...